Max Planck Institute of Psychiatry

What Max Planck Institute of Psychiatry does

The Max Planck Institute of Psychiatry (Max-Planck-Institut für Psychiatrie) is a non-profit research institute and psychiatric hospital located in Munich, Germany. Founded in 1924 and operating as part of the Max Planck Society (Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.), it functions as a "Forschungsklinik" (research clinic) that integrates direct patient care with translational psychiatric research focused on stress-related disorders including depression, anxiety disorders, schizophrenia, and psychosis. The institute serves patients from across Germany while simultaneously conducting basic and clinical research, with research leadership including Director Prof. Elisabeth Binder, MD, PhD.

The institute operates six inpatient wards, multiple specialized outpatient clinics (depression, anxiety, sleep medicine, neurology, neurostimulation including electroconvulsive therapy, memory clinic, early detection, Long-COVID/ME/CFS, and private patients), day clinics with transition programs for young adults, and diagnostic services. Its core technology stack combines neuroimaging, genetics, molecular biology, and clinical research methodologies, anchored by a Neuroimaging Core Unit and supported by clinical core units. The institute is the only center in Oberbayern (Upper Bavaria) offering both invasive and non-invasive vagus nerve stimulation for treatment-resistant depression in patients with implants, representing a regional clinical monopoly.

Funding is derived from three primary streams: government research grants (German Federal Ministry of Education and Research/BMBF, Deutsche Forschungsgemeinschaft/DFG, European Union programs), clinical services billed through German statutory and private health insurance frameworks, and competitive external research grants. Educational activities include the IMPRS-TP doctoral program jointly offered with LMU Munich and Max Planck Institute of Neurobiology, attracting international PhD candidates. The institute maintains global research collaborations with Weizmann Institute of Science, CONICET Buenos Aires, and McLean Hospital at Harvard, and disseminates findings through peer-reviewed publications and scientific conferences.

Name

Max Planck Institute of Psychiatry

Legal name

Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.

Website

https://psych.mpg.de

Company type

Private

Founded year

1924

Operating status

Operating

Headcount range

501–1,000 employees

Short description

The Max Planck Institute of Psychiatry is a Munich-based non-profit research hospital within the Max Planck Society, integrating translational psychiatric research on depression, anxiety, and schizophrenia with direct clinical patient care, doctoral training, and international scientific collaborations.

Ownership category

akta.pro rank

Product category

Psychiatric Research and Clinical Services

NAICS

Offices of Physicians, Mental Health Specialists (621112), Psychiatric and Substance Abuse Hospitals (62221), Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Inpatient Psychiatric Hospitals (HLAFAHAH)

akta.pro secondary industries

Crisis Stabilization Units & Psychiatric Emergency Services (HLAFACAH), Outpatient Mental Health & Counseling Clinics (HLAFABAC), Inpatient Psychiatric Hospitals & Units (HLAFACAB)

Keywords

• Psychiatric research
• Clinical psychiatry
• Mental health treatment
• Translational neuroscience
• Psychiatric hospital services

Headquarters

HQ city

Munich

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

1. Government Research Funding: As part of the Max Planck Society, the institute is primarily funded through federal and state government grants, including funding from the German Federal Ministry of Education and Research (BMBF), Deutsche Forschungsgemeinschaft (DFG), and European research programs
2. Clinical Services Revenue: Revenue generated from patient treatment services including inpatient wards, outpatient clinics, day clinics, and diagnostic services for psychiatric conditions
3. Research Grants and Awards: External competitive research funding from foundations, European Union programs, and international research organizations supporting specific research projects and programs

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

The Max Planck Institute of Psychiatry operates an integrated research clinic (Forschungsklinik) that delivers psychiatric inpatient, outpatient, and day-clinic treatment for stress-related disorders such as depression, anxiety, schizophrenia, and psychosis while simultaneously conducting basic, translational, and clinical research on the biological causes and personalized therapies of these conditions. It also offers structured clinical research studies, dedicated research core units (including Neuroimaging), and graduate training through the IMPRS-TP international PhD program.

Product overview

The Max Planck Institute of Psychiatry is a research hospital that operates as a single integrated offering combining clinical psychiatric care with fundamental and translational research. The institute provides inpatient, outpatient, and day clinic psychiatric services for stress-related disorders including depression and anxiety. Research activities are organized through departments (Binder, Falkai, Gogolla), clinical research studies, and scientific core units including neuroimaging. Educational offerings include the IMPRS-TP PhD program and scientific seminar series. The institute does not offer commercial software products.

Differentiator

Problem solved

Functional benefit

Brands

• IMPRS-TP: International Max Planck Research School for Translational Psychiatry - a PhD program offering interdisciplinary training in molecular, cellular and systemic psychiatric research, offered jointly with LMU Munich and other partners.

Products and services

• Inpatient Wards Inpatient psychiatric care at the institute's Munich research clinic, including specialized wards for young adults, patients over 60, private patients, complex psychiatric cases with addiction focus, and acute/intensive treatment, delivered within an integrated research environment.
• Outpatient Clinics

Quantifiable outcome

• Rapid translation of research findings to clinical applications due to integrated research clinic model
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eleven partnerships are on record, tiered core, supporting and minor.

• LMU Munich - Department of Psychiatry and PsychotherapycoreStrategic or Co-development PartnerCore partner in the International Max Planck Research School for Translational Psychiatry (IMPRS-TP), providing clinical training and research opportunities for PhD students in psychiatric research.
• LMU Munich - Center for Neuropathology and Prion ResearchcoreStrategic or Co-development PartnerFaculty member in IMPRS-TP, contributing expertise in neuropathology and prion research to the translational psychiatry graduate program.
• LMU Munich - Institute of Psychiatric Phenomics and GenomicscoreStrategic or Co-development PartnerPartner in IMPRS-TP providing research focus on psychiatric phenomics and genomics for translational research training.
• LMU Munich - Department of NeuroanatomycoreStrategic or Co-development PartnerFaculty contributor to IMPRS-TP focusing on neuroanatomy aspects of psychiatric research training.
• Max Planck Institute of NeurobiologycoreStrategic or Co-development PartnerKey partner in IMPRS-TP providing basic neuroscience research training complementing clinical psychiatric research at MPI Psychiatry.
• Weizmann Institute of Science, IsraelsupportingStrategic or Co-development PartnerInternational research collaboration partner providing opportunities for student and researcher exchanges in neuroscience and psychiatry research.
• Biomedicine Research Institute of Buenos Aires - CONICET, ArgentinasupportingStrategic or Co-development PartnerInternational collaboration partner facilitating research exchanges and joint studies in biomedical and psychiatric research.
• McLean Hospital at Harvard University, USAsupportingStrategic or Co-development PartnerInternational collaboration with Harvard-affiliated psychiatric research institution, enabling researcher exchanges and joint translational psychiatry research with Dr. Kerry Ressler.
• EU Office BavariasupportingGTM or Marketing PartnerEU funding support office providing guidance on European research funding opportunities for Munich-area Max Planck institutes.
• pme Family ServiceminorOthersExternal service provider offering family care support including childcare, elderly care, and work-life balance services for institute employees.
• Minerva-FemmeNetsupportingStrategic or Co-development PartnerMax Planck Society network connecting female scientists with mentors for career development and work-life balance guidance.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• McLean Hospital (Harvard Medical School): Premier US psychiatric hospital affiliated with Harvard, combining specialized inpatient care with world-class psychiatric research. Documented research partner of the institute (Kerry Ressler collaboration) and comparable in translational psychiatry mission.
• University Hospital of Psychiatry Zurich (PUK): Swiss psychiatric university hospital combining clinical care with translational research on depression and schizophrenia. Comparable in integrating specialized clinical services with research programs in German-speaking Europe.
• King's College London – Institute of Psychiatry, Psychology & Neuroscience (IoPPN): Leading European academic institution combining clinical psychiatric services with neuroscience and psychology research. Directly comparable in scale and translational research focus on mood and psychotic disorders.
• Karolinska Institutet – Department of Neuroscience: Major Scandinavian research university with leading programs in psychiatric neuroscience, stress-related disorders, and translational research. Comparable in mission and research output to the Max Planck Institute of Psychiatry.
• Central Institute of Mental Health (ZI Mannheim): Another major German psychiatric research clinic combining inpatient care with translational research on depression, schizophrenia, and addiction. Directly comparable in mission, structure, and integration of clinical services with research.
• LMU Munich – Department of Psychiatry and Psychotherapy: University hospital psychiatric department in Munich with core IMPRS-TP partnership. Operates inpatient, outpatient, and research services on similar disorders, sharing faculty and students with the Max Planck Institute.
• Charité – Department of Psychiatry and Psychotherapy: One of Europe's largest university hospital psychiatric departments with extensive inpatient, outpatient, and research programs on depression and psychosis. Comparable translational model and patient population to the Max Planck Institute of Psychiatry.
• Max Planck Institute of Neurobiology: Sister Max Planck institute in Munich with complementary basic neuroscience research programs. Core IMPRS-TP partner providing basic science infrastructure that supports translational psychiatry research.

Emerging players

• Weizmann Institute of Science – Department of Brain Sciences: Israeli research institution with active neuroscience and psychiatric research programs. Documented international research partner of the Max Planck Institute of Psychiatry for neuroscience and translational research collaboration.

Broad incumbents

• National Institute of Mental Health (NIMH): US federal agency for mental health research, intramural research program in Bethesda. Operates as a much larger psychiatric research enterprise with comparable translational focus on stress-related disorders, but as a government agency rather than a clinical care provider.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks4 records

Key highlights6 records

Customer concentration

• Xx.com/mpi_psychiatry
• YouTubeyoutube.com/channel/UChzU2jE-vOBDkS9pSAi6WYg
• Facebookfacebook.com/MPIPsychiatrie
• LinkedInlinkedin.com/company/max-planck-institut-f%C3%BCr-psychiatrie
• Instagraminstagram.com/mpi_psychiatry

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Max Planck Institute of Psychiatry